透過您的圖書館登入
IP:3.133.12.172
  • 期刊

Cell Cycle Regulation in the Estrogen Receptor Beta (ESR2)-Overexpressing Hep3B Hepatocellular Carcinoma Cell Line

本篇文章尚未正式出版,請點選「加入追蹤」跟進後續出版資訊!

並列摘要


Epidemiological studies and experimental data have shown that the incidences of hepatocellular carcinoma in men are more frequent than in women. Evidence suggests that imbalance of hormones, including estrogen, androgen, prolactin, and growth hormone, modifies liver tumorigenesis. In this present study, we investigated how estrogen and estrogen receptor 2 (ESR2), regulates the cell cycle mechanism in Hep3B hepatocellular carcinoma cell line. Our results showed that ESR2 overexpression in the presence of 10^(-8) M 17-β-estradiol downregulated c-myc and cyclin D1 expression and simultaneously upregulated p27 expression. However, flow cytometry and MTT assays showed only minor G_1 phase arrest without affecting cell viability. Taken together, these observations indicate that ESR2 is required to lower tumorigenesis in males by altering cell cycle proteins in a ligand-dependent manner.

並列關鍵字

c-myc cyclin D1 ESR2 Hep3B cells

參考文獻


Bardin, A.,Hoffmann, P.,Boulle, N.,Katsaros, D.,Vignon, F.,Pujol, P.,Lazennec, G.(2004).Involvement of estrogen receptor β in ovarian carcinogenesis.Cancer Res..64,5861-5869.
Di Maio, M.,De Maio, E.,Perrone, F.,Pignata, S.,Daniele, B.(2002).Hepatocellular carcinoma: systemic treatments.J. Clin. Gastroenterol..35,S109-S114.
Doisneau-Sixou, S.F.,Sergio, C.M.,Carroll, J.S.,Hui, R.,Musgrove, E.A.,Sutherland, R.L.(2003).Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.Endocr.-Relat. Cancer.10,179-186.
El-Serag, H.B.(2002).Hepatocellular carcinoma: an epidemiologic view.J. Clin. Gastroenterol..35,S72-S78.
Fan, M.J.,Huang-Liu, R.,Shen, C.Y.,Ju, D.T.,Lin, Y.M.,Pai, P.,Huang, P.Y.,Ho, T.J.,Tsai, F.J.,Tsai, C.H.,Huang, C.Y.(2014).Reduction of TLR4 mRNA stability and protein expressions through inhibiting cytoplasmic translocation of HuR transcription factor by E2 and/or ERα in LPS-treated H9c2 cardiomyoblast cells.Chinese J. Physiol..57,8-18.

延伸閱讀